Literature DB >> 6140847

Cimetidine-drug interactions.

A J Sedman.   

Abstract

The use of cimetidine, the histamine H2 receptor antagonist, is associated with a relatively low incidence of adverse reactions. However, its liberal use has led to the identification of several clinically significant cimetidine-drug interactions that can lead to drug accumulation, toxicity, and life-threatening sequelae. A review of the literature and the clinical significance and physiologic basis of these interactions are presented. Recommended management of cimetidine-drug interactions is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6140847     DOI: 10.1016/0002-9343(84)90758-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  20 in total

Review 1.  Interactions between non-steroidal anti-inflammatory drugs and H2-receptor antagonists or prostaglandin analogues.

Authors:  J S Dixon; M C Page
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

Review 2.  Haematological adverse effects of histamine H2-receptor antagonists.

Authors:  J P Aymard; B Aymard; P Netter; B Bannwarth; P Trechot; F Streiff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 4.  Dosage regimen of cimetidine reviewed. Possible drug accumulation after multiple oral doses.

Authors:  J Prandota; I J Smith; J T Wilson
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Pharmacokinetics of cimetidine after subchronic administration.

Authors:  T W Chin; M Spino; S M MacLeod; W A Mahon; S J Soldin
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide.

Authors:  U Klotz; P Arvela; B Rosenkranz
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Effect of concomitant administration of cimetidine and ranitidine on the pharmacokinetics and electrocardiographic effects of terfenadine.

Authors:  P K Honig; D C Wortham; K Zamani; D P Conner; J C Mullin; L R Cantilena
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 8.  Clinical pharmacokinetics of mibefradil.

Authors:  H A Welker; H Wiltshire; R Bullingham
Journal:  Clin Pharmacokinet       Date:  1998-12       Impact factor: 6.447

9.  Further insight into the stereoselective interaction between warfarin and cimetidine in man.

Authors:  I Niopas; S Toon; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

Review 10.  Pharmacokinetic drug interactions with ACE inhibitors.

Authors:  H Shionoiri
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.